By Kolade Adeyemo / Jambar Contributor Breast cancer is one of the most prevalent cancers worldwide, affecting millions of ...

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...

Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol ...

As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...

Breast cancer is a heterogeneous malignancy that can be divided into several molecular subtypes according to estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 ...

People assigned female at birth have a predisposition for migraines, especially in adolescence and around menopause. Find a list of causes here.

It makes up about 70% of all breast cancer cases. HR+/HER2- breast cancer involves tumor cells that test positive for hormone receptors and negative for HER2 proteins. Cancer cells with estrogen or ...

Progesterone is the other major sex hormone, in addition to estrogen, produced by the female body. Progesterone is involved in regulating the female menstrual cycle. Hormone receptor-positive breast ...

Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...

Development of a highly sensitive in vitro system to detect and discriminate between vitamin D receptor agonists and antagonists based on split-luciferase technique.